Over the current book year the total revenue will be 24,2 billion USD (consensus estimates). This is slightly more than 2019's revenue of 22,45 billion USD.
The analysts expect for 2020 a net profit of 8,8 billion USD. According to most of the analysts the company will have a profit per share for this book year of 6,99 USD. Based on this the price/earnings-ratio is 9,06.
Gilead Sciences's market capitalization is based on the number of outstanding shares around 81,18 billion USD. The Gilead Sciences stock was the past 12 months quite volatile. Since last October the stock is 4 percent higher. This year the stock price moved between 62 and 86 dollar.
Click here for dividend Gilead Sciences. On Monday the stock closed at 63,32 USD.
Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.